Brief: 3Sbio's Unit Enters Collaboration Agreement With Samsung Bioepis
07/01/2019 01:25
Jan 7 (Reuters) - 3SBio Inc 1530.HK :
* HONGKONG SANSHENG GETS, EXCLUSIVE LICENCES TO INTELLECTUAL
PROPERTY RIGHTS FOR CLINICAL DEVELOPMENT OF MULTIPLE BIOSIMILAR
CANDIDATES
Source text for Eikon: ID:nHKS1Hc0cJ
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))